Breast Cancer Clinical Trials in Houston, TX

Breast Cancer Clinical Trials in Houston, TX

View the best 10 breast cancer medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in Houston, Texas

Here are the top 10 medical studies for breast cancer in Houston, Texas

Image of University of Alabama at Birmingham in Birmingham, United States.

Oral Paclitaxel + Encequidar + Dostarlimab (TSR-042) + Carboplatin with or without trastuzumab +8 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing new drugs for breast cancer and trying to find which early indicators predict success for different types of tumors.
Image of University of Texas MD Anderson Cancer Center in Houston, United States.

Tc99m sestamibi

Recruiting3 awards5 criteria
This trial looks at using technetium Tc-99m sestamibi to see if it can predict how well patients with breast cancer that has spread to nearby tissues will respond to chemotherapy.
Image of University of Alabama at Birmingham in Birmingham, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer treatment involving two drugs. It will study the side effects and if the drugs are effective in treating triple-negative breast cancer.
Image of University of Miami/Sylvester at Plantation in Plantation, United States.

Retifanlimab +1 More

PD-1 Inhibitor

Verified
Recruiting1 awardPhase 1 & 2
This trial is testing a new combination therapy for patients with advanced breast cancer who have failed other treatments.
Image of UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138) in San Francisco, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is comparing the efficacy of two different treatments for triple negative breast cancer - olaparib plus pembrolizumab versus chemotherapy plus pembrolizumab. The primary hypotheses are that olaparib plus pembrolizumab will be superior to chemotherapy plus pembrolizumab in terms of progression-free survival and overall survival.
Image of UC Irvine Health/Chao Family Comprehensive Cancer Center in Orange, United States.

Nab-paclitaxel +2 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing how well a combination of chemotherapy drugs, immunotherapy drugs, and a personalized vaccine work in treating patients with metastatic triple negative breast cancer.
Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial is studying whether a combination of the standard chemotherapy regimen for breast cancer plus the experimental drug atezolizumab is more effective than the standard chemotherapy regimen plus a placebo.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing radiation therapy with or without olaparib to see which is more effective in treating inflammatory breast cancer.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Doxorubicin Hydrochloride +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is testing two different chemotherapy combinations to treat triple negative breast cancer to see which is more effective.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

WBI

Radiation Therapy

Recruiting1 award17 criteria
This trial is comparing two types of radiation therapy to treat early-stage breast cancer.

Popular filter options for breast-cancer houston trials

Phase 3 Clinical Trials

View 99 phase 3 medical studies.

Clinical Trials With No Placebo

View 99 medical studies that do not have a placebo group.

View More Breast-cancer Houston Trials

See another 81 medical studies focused on breast-cancer houston.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.